Opioid maker Collegium buys N.C. competitor for $604M By: Boston Business Journal via Business Journals February 14, 2022 at 12:18 PM EST The Stoughton drug company is shelling out $604 million to buy a Raleigh, N.C.-based competitor called BioDelivery Sciences International Inc. Read More >>
